Rituximab’s Second Act: Rethinking B-Cell Depletion for Lupus Treatment
A new review maps where the off-label anti-CD20 antibody rituximab fits in the treatment of systemic lupus erythematosus, from refractory ...
A new review maps where the off-label anti-CD20 antibody rituximab fits in the treatment of systemic lupus erythematosus, from refractory ...
Multiple myeloma is entering an era of unprecedented therapeutic choice—and equally unprecedented uncertainty. A new clinical perspective by C.R. Tan ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine